Top 10 Companies in the Global Lactulose API Market (2026): Market Leaders Powering Growth

The Global Lactulose API market is poised for significant expansion as chronic disease prevalence rises and pharmaceutical demand increases. With a projected value of USD 345.6 million by 2034 and a CAGR of 6.7% from 2025 to 2034, the market is set to deliver robust growth for players across the value chain.

Download the full research report for detailed insights:

Global Lactulose API Market – View in Detailed Research Report

The Global Lactulose API market size was valued at USD 234.5 million in 2025 and is projected to reach USD 345.6 million by 2034, at a CAGR of 6.7% during the forecast period 2025–2034.

The United States Lactulose API market size was valued at USD 67.8 million in 2025 and is projected to reach USD 98.4 million by 2034, at a CAGR of 6.4% during the forecast period 2025–2034.

Lactulose API is a synthetic sugar used in pharmaceutical applications, particularly for treating constipation and hepatic encephalopathy. The global market is experiencing steady growth, driven by increasing chronic disease prevalence and pharmaceutical applications. In 2023, total production reached 25,000 metric tons, with pharmaceutical formulations accounting for 80% of demand. The high‑purity grade segment is the fastest‑growing at 7.5% annually. The market saw a 20% increase in demand for crystalline forms in 2023, reflecting formulation preferences. Liquid concentrate dominates with a 65% market share, while crystalline forms are growing at 8.5% annually. Europe leads with a 40% market share, while Asia‑Pacific is the fastest‑growing region at 7.8% CAGR. The industry is focusing on developing improved purification methods, with a 25% growth in R&D investments for quality enhancement.

Top 10 Companies in the Global Lactulose API Market (2026)

---

10️⃣ 1. Abbott

Headquarters: Abbott Park, Illinois, USA
Key Offering: High‑purity Lactulose API, Crystalline and Liquid forms

Abbott has a long history of producing pharmaceutical grade excipients. Their Lactulose API line is widely used by contract manufacturers for constipation and hepatic encephalopathy formulations.

Sustainability & Growth Initiatives:

• Investing in green chemistry processes to reduce solvent usage.
• Partnerships with academic institutions for advanced purification technologies.
• Commitment to achieve carbon neutrality by 2035.

---

9️⃣ 2. Morinaga

Headquarters: Tokyo, Japan
Key Offering: Crystalline Lactulose API for pharmaceutical and food industries

Morinaga supplies high‑quality Lactulose API to both pharmaceutical manufacturers and the food sector, emphasizing purity and regulatory compliance.

Sustainability & Growth Initiatives:

• Expansion of production capacity in Asia‑Pacific to meet rising demand.
• Implementation of zero‑liquid‑waste processes.
• R&D focus on bio‑based feedstock for Lactulose synthesis.

---

8️⃣ 3. Solactis

Headquarters: Paris, France
Key Offering: Liquid Lactulose API and crystallization services

Solactis specializes in delivering both liquid and crystalline forms, supporting pharmaceutical companies with tailored API solutions.

Sustainability & Growth Initiatives:

• Investment in renewable energy for manufacturing facilities.
• Collaboration with European regulators to streamline approval processes.
• Development of a proprietary crystallization technology to improve yield.

---

7️⃣ 4. Fresenius Kabi

Headquarters: Bad Homburg, Germany
Key Offering: Pharmaceutical grade Lactulose API for injectable and oral formulations

Fresenius Kabi’s API portfolio includes Lactulose, catering to both oral and parenteral drug developers.

Sustainability & Growth Initiatives:

• Adoption of closed‑loop water recycling systems.
• Strategic alliances with global contract manufacturers.
• Focus on continuous process improvement to reduce carbon footprint.

---

6️⃣ 5. Illovo

Headquarters: Johannesburg, South Africa
Key Offering: High‑purity Lactulose API for emerging markets

Illovo provides affordable, high‑quality Lactulose API to pharmaceutical companies in Africa and the Middle East.

Sustainability & Growth Initiatives:

• Local sourcing of raw materials to support regional economies.
• Implementation of solar power in production facilities.
• Engagement in community health programs focused on chronic disease management.

---

5️⃣ 6. Biofac

Headquarters: Shanghai, China
Key Offering: Crystalline and Liquid Lactulose API for domestic and export markets

Biofac is a leading API manufacturer in China, supplying both crystalline and liquid forms to pharmaceutical firms worldwide.

Sustainability & Growth Initiatives:

• Investment in advanced purification units to increase yield.
• Participation in China’s green manufacturing pilot programs.
• Collaboration with universities for process innovation.

---

4️⃣ 7. Dandong Kangfu

Headquarters: Dandong, China
Key Offering: High‑purity Liquid Lactulose API for pharmaceutical applications

Dandong Kangfu focuses on delivering liquid Lactulose API with stringent quality controls, catering to both domestic and export markets.

Sustainability & Growth Initiatives:

• Adoption of energy‑efficient crystallization processes.
• Partnerships with global health organizations to expand access.
• R&D into alternative feedstocks to reduce dependency on petrochemicals.

---

3️⃣ 8. Pfizer

Headquarters: New York, USA
Key Offering: Proprietary Lactulose API for research and development

Pfizer’s API division supplies Lactulose for clinical trials and commercial drug development, emphasizing regulatory compliance and scalability.

Sustainability & Growth Initiatives:

• Investment in green chemistry initiatives across its global sites.
• Partnerships with academic institutions for novel synthesis routes.
• Commitment to reduce CO₂ emissions by 30% by 2030.

---

2️⃣ 9. Bayer

Headquarters: Leverkusen, Germany
Key Offering: Pharmaceutical grade Lactulose API for over‑the‑counter and prescription products

Bayer supplies Lactulose API to a wide range of pharmaceutical manufacturers, ensuring consistent quality and supply reliability.

Sustainability & Growth Initiatives:

• Implementation of circular economy practices in raw material sourcing.
• Investment in renewable energy projects at manufacturing plants.
• Collaboration with global health agencies to improve drug accessibility.

---

1️⃣ 10. Johnson & Johnson

Headquarters: New Brunswick, New Jersey, USA
Key Offering: High‑purity Lactulose API for consumer health products

Johnson & Johnson’s API unit delivers Lactulose for its consumer health portfolio, supporting both over‑the‑counter and prescription products.

Sustainability & Growth Initiatives:

• Use of renewable electricity across all production sites.
• Adoption of water‑recycling technologies.
• Commitment to zero‑defect manufacturing processes.

---

Download FREE Sample Report: https://www.24chemicalresearch.com/download-sample/281805/global-lactulose-api-market-2024-336

Get Full Report Here: https://www.24chemicalresearch.com/reports/281805/global-lactulose-api-market-2024-336

---

🌍 Outlook: The Future of Lactulose API Is Growing

The Lactulose API market is undergoing a dynamic shift, with increased focus on high‑purity grades, advanced crystallization technologies, and expansion into emerging markets. Regulatory support for chronic disease management and growing pharmaceutical applications are driving demand across North America, Europe, and Asia‑Pacific.

📈 Key Trends Shaping the Market:

• Rapid adoption of high‑purity Lactulose API for advanced drug delivery systems.
• Expansion of R&D investments to improve purification methods and reduce cost.
• Growing demand for liquid concentrate forms in oral formulations.
• Strategic partnerships and acquisitions among API manufacturers to broaden product portfolios.
• Increased regulatory scrutiny and emphasis on quality compliance.

The companies listed above are not only leading the Lactulose API supply chain but are also spearheading innovation and sustainability in the pharmaceutical industry.